Stange Jonathan P, Eisner Lori R, Hölzel Britta K, Peckham Andrew D, Dougherty Darin D, Rauch Scott L, Nierenberg Andrew A, Lazar Sara, Deckersbach Thilo
Department of Psychology, Temple University, USA.
J Psychiatr Pract. 2011 Nov;17(6):410-9. doi: 10.1097/01.pra.0000407964.34604.03.
Bipolar disorder is associated with impairments in cognition, including difficulties in executive functioning, even when patients are euthymic (neither depressed nor manic). The purpose of this study was to assess changes in self-reported cognitive functioning in patients with bipolar disorder who participated in an open pilot trial of mindfulness-based cognitive therapy (MBCT). Following MBCT, patients reported significant improvements in executive functioning, memory, and ability to initiate and complete tasks, as measured by the Behavior Rating Inventory of Executive Function (BRIEF) and the Frontal Systems Behavior Scale (FrSBe). Changes in cognitive functioning were correlated with increases in mindful, nonjudgmental observance and awareness of thoughts, feelings, and sensations, and were not associated with decreases in depression. Improvements tended to diminish after termination of treatment, but some improvements, particularly those in executive functioning, persisted after 3 months. These results provide preliminary evidence that MBCT may be a treatment option that can be used as an adjunct to medication to improve cognitive functioning in bipolar disorder.
双相情感障碍与认知功能损害有关,包括执行功能方面的困难,即使患者处于心境正常状态(既不抑郁也不躁狂)。本研究的目的是评估参与基于正念的认知疗法(MBCT)开放性试验的双相情感障碍患者自我报告的认知功能变化。接受MBCT治疗后,通过执行功能行为评定量表(BRIEF)和额叶系统行为量表(FrSBe)测量,患者报告在执行功能、记忆以及发起和完成任务的能力方面有显著改善。认知功能的变化与正念、对思想、情感和感觉的非评判性观察及意识的增加相关,且与抑郁程度的降低无关。治疗结束后改善趋势有所减弱,但一些改善,尤其是执行功能方面的改善,在3个月后仍然存在。这些结果提供了初步证据,表明MBCT可能是一种可作为药物辅助治疗手段来改善双相情感障碍患者认知功能的治疗选择。